Trial intelligence / Profile preview

Anti-TNF (Enbrel) for acute analgesic effect in lower back and leg pain

2005-003722-26Phase 2Suspended

Sponsor
Barts Health NHS Trust
Start
Dec 2005
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in lumbodynia (LBP) and leg pain comparing Enbrel with Placebo (2 arms). Started Dec 2005; status: suspended.

02

Drugs

etanercept
03

Conditions

lumbodynia (LBP)leg pain

Beyond the preview

Go deeper on 2005-003722-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003722-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call